The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Fenafluke 5% w/v Oral Suspension

50, 50 milligram(s)/millilitre Oral suspension

Pharvet (Ireland) LtdVPA10462/003/001

Main Information

Trade NameFenafluke 5% w/v Oral Suspension
Active SubstancesFenbendazole
Strength50, 50 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderPharvet (Ireland) Ltd
Licence NumberVPA10462/003/001

Group Information

ATC CodeQP52AC13 fenbendazole
QP52AX Other anthelmintic agents
Therapeutic ClassEndoparasiticide


Licence Issued18/09/1998
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back